Evidence map›Paper›PMID 38178196›Full record

ArticleJournal of neuroinflammation2024

Autophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behaviors in mice.

Ya-Jing Zhu, Jing Huang, Ru Chen, Yu Zhang, Xin He, Wen-Xin Duan, Yuan-Lei Zou, Meng-Mei Sun, Hui-Li Sun, Si-Min Cheng and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Ubiquitination in hepatocellular carcinoma immunity.Journal of translational medicine · 2025
    Review
  12. Article
  13. Exploration of the Mechanisms ofCurrent issues in molecular biology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ya-Jing Zhu *Department of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Jing Huang *Department of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Ru ChenDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Yu ZhangDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Xin HeDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Wen-Xin DuanDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Yuan-Lei ZouDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Meng-Mei SunDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Hui-Li SunDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Si-Min ChengDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Hao-Chuan WangDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.
Hao ZhangDepartment of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, 230032, People's Republic of China.
Wen-Ning WuDepartment of Pharmacology & Research Centre for Neurological Disorders, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China. wuwn28@ahmu.edu.cn.
Anhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CN

Funding

National Natural Science Foundation of China 82171449Scientific Research Promotion Plan of Anhui Medical University 2020xkjT004
6 · The paper itself

Abstract

backgroundMajor depressive disorder (MDD) is a common but severe psychiatric illness characterized by depressive mood and diminished interest. Both nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing 1 (NLRP1) inflammasome and autophagy have been reported to implicate in the pathological processes of depression. However, the mechanistic interplay between NLRP1 inflammasome, autophagy, and depression is still poorly known.

methodsAnimal model of depression was established by chronic social defeat stress (CSDS). Depressive-like behaviors were determined by social interaction test (SIT), sucrose preference test (SPT), open field test (OFT), forced swim test (FST), and tail-suspension test (TST). The protein expression levels of NLRP1 inflammasome complexes, pro-inflammatory cytokines, phosphorylated-phosphatidylinositol 3-kinase (p-PI3K)/PI3K, phosphorylated-AKT (p-AKT)/AKT, phosphorylated-mechanistic target of rapamycin (p-mTOR)/mTOR, brain-derived neurotrophic factor (BDNF), phosphorylated-tyrosine kinase receptor B (p-TrkB)/TrkB, Bcl-2-associated X protein (Bax)/B-cell lymphoma-2 (Bcl2) and cleaved cysteinyl aspartate-specific proteinase-3 (caspase-3) were examined by western blotting. The mRNA expression levels of pro-inflammatory cytokines were tested by quantitative real-time PCR. The interaction between proteins was detected by immunofluorescence and coimmunoprecipitation. Neuronal injury was assessed by Nissl staining. The autophagosomes were visualized by transmission electron microscopy. Nlrp1a knockdown was performed using an adeno-associated virus (AAV) vector containing Nlrp1a-shRNA-eGFP infusion.

resultsCSDS exposure caused a bidirectional change in hippocampal autophagy function, which was activated in the initial period but impaired at the later stage. In addition, CSDS exposure increased the expression levels of hippocampal NLRP1 inflammasome complexes, pro-inflammatory cytokines, p-PI3K, p-AKT and p-mTOR in a time-dependent manner. Interestingly, NLRP1 is immunoprecipitated with mTOR but not PI3K/AKT and CSDS exposure facilitated the immunoprecipitation between them. Hippocampal Nlrp1a knockdown inhibited the activity of PI3K/AKT/mTOR signaling, rescued the impaired autophagy and ameliorated depressive-like behavior induced by CSDS. In addition, rapamycin, an autophagy inducer, abolished NLRP1 inflammasome-driven inflammatory reactions, alleviated depressive-like behavior and exerted a neuroprotective effect.

conclusionsAutophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behavior in mice and the regulation of autophagy could be a valuable therapeutic strategy for the management of depression.

Indexed as

DepressionMajor Depressive DisorderAdaptor Proteins, Signal TransducingAnimalsAntidepressive AgentsApoptosis Regulatory ProteinsAutophagyCytokinesHippocampusInflammasomesMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSirolimusTOR Serine-Threonine KinasesAdaptor Proteins, Signal TransducingAntidepressive AgentsApoptosis Regulatory ProteinsCytokinesInflammasomesNALP1 protein, mousePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSirolimusTOR Serine-Threonine KinasesAutophagyCSDSMDDmTORNLRP1 inflammasomePI3K/AKT

Identifiers

PMID38178196
PMCPMC10765763
OpenAlexW4390583134

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.